• Connect with us
    • Information
      • About Us
      • Contact Us
      • Careers
      • Partnerships
      • Advertise With Us
      • Authors
      • Browse Topics
      • Events
      • Disclaimer
      • Privacy Policy
    • NORTH AMERICA EDITION
      Australia
      North America
      World
    Login
    Investing News NetworkYour trusted source for investing success
    • NORTH AMERICA EDITION
      North America
      Australia
      World
    • My INN
    Videos
    Companies
    Press Releases
    Private Placements
    SUBSCRIBE
    • Reports & Guides
      • Market Outlook Reports
      • Investing Guides
    • Button
    Resource
    • Precious Metals
    • Battery Metals
    • Base Metals
    • Energy
    • Critical Metals
    Tech
    Life Science
    Gold Market
    Gold News
    Gold Stocks
    • Gold Market
    • Gold News
    • Gold Stocks
    market news

    Franco-Nevada Announces Record Results for 2017

    Amanda Kay
    Mar. 08, 2018 09:49AM PST
    Gold Investing

    Franco-Navada (TSE: FNV) is pleased to announce its results for 2017. The company states that the year brought record growth and results at the high end of its guidance for the year. Highlights for the year include 497,745 gold equivalent ounces, representing a seven percent increase for the year. Plus $675 million in revenue, which …

    Franco-Navada (TSE: FNV) is pleased to announce its results for 2017. The company states that the year brought record growth and results at the high end of its guidance for the year. Highlights for the year include 497,745 gold equivalent ounces, representing a seven percent increase for the year. Plus $675 million in revenue, which represents a 10.6 percent increase year over year.

    David Harquail, CEO commented:

    “I am pleased that Franco-Nevada’s 10th full year since its IPO was its best year ever. We achieved record results that were at the high end of our guidance for 2017. We are now looking forward to another phase of growth through 2022 with the ramp-up of Cobre Panama over 2019-2022, the first phase expansion of Tasiast later this year and the second phase in 2020, the expansion or start-up of a number of smaller mines over 2018 and 2019 and the 50% expansion of Stillwater by 2021. The on-going full-field development of our U.S. oil & gas royalties is tracking ahead of our original expectations. On top of that, our business development team has been very active adding new investments in precious metals, oil & gas and other minerals. FrancoNevada remains debt free and is well positioned for another 10 years of success.”

    Click here to read the full press release.

    market newsrecord resultscobre panamadavid harquailbusiness development2017 results
    The Conversation (0)

    Go Deeper

    AI Powered
    Sandstorm Gold Royalties Reports Record Operating Results in Second Quarter 2025

    Sandstorm Gold Royalties Reports Record Operating Results in Second Quarter 2025

    Franco-Nevada

    Franco-Nevada

    Latest News

    Auking Completes A$5m Riverfort Facility

    Review at Leonora North Provides Clear Focus for Future Work

    North American Mining Conferences Presentation

    Fortune Bay: Maximizing Shareholder Value in Gold and Uranium

    Casablanca Geophysics Highlights Antimony Targets at Depth

    More News

    Outlook Reports

    Resource
    • Precious Metals
      • Gold
      • Silver
    • Battery Metals
      • Lithium
      • Cobalt
      • Graphite
    • Energy
      • Uranium
      • Oil and Gas
    • Base Metals
      • Copper
      • Nickel
      • Zinc
    • Critical Metals
      • Rare Earths
    • Industrial Metals
    • Agriculture
    Tech
      • Artificial Intelligence
      • Cybersecurity
      • Gaming
      • Cleantech
      • Emerging Tech
    Life Science
      • Biotech
      • Cannabis
      • Psychedelics
      • Pharmaceuticals

    Featured Stocks

    More featured stocks

    Browse Companies

    Resource
    • Precious Metals
    • Battery Metals
    • Energy
    • Base Metals
    • Critical Metals
    Tech
    Life Science
    MARKETS
    COMMODITIES
    CURRENCIES
    ×